With an experienced team of experts in the fields of neuroscience and pharmacology, Pasithea is developing new molecular entities for the treatment of CNS disorders, including Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis,..
Relevance: 13.282178